한글목차

세계 갑상선 절제 기기 시장의 미래는 병원, 외래수술센터(ASC), 암 전문센터 시장에 기회가 있어 유망한 것으로 전망됩니다. 세계 갑상선 절제 기기 시장은 2025-2031년 연평균 복합 성장률(CAGR) 9.7%를 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 갑상선암 발병률 증가와 최소침습 수술에 대한 선호도 증가입니다.

• Lucintel의 예측에 따르면, 유형별로는 고주파 절제술이 신속하고 안전하며 최소침습적으로 수술을 대체할 수 있다는 장점으로 인해 예측 기간 동안 큰 부문을 차지할 것으로 예측됩니다.
• 최종 용도별로는 병원이 가장 큰 부문을 차지할 것으로 보입니다.
• 지역별로는 북미가 갑상선암 발병률 증가와 이 지역의 주요 기업의 존재로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것으로 보입니다.

갑상선 절제술 장비 시장의 전략적 성장 기회

갑상선 절제 기기 시장은 최소침습적 치료에 대한 수요 증가를 활용하고자 하는 이해관계자들에게 많은 전략적 성장 기회를 제공합니다. 갑상선 질환에 대한 인식이 높아지고 기술 혁신이 진행됨에 따라 몇 가지 확장의 길이 열리고 있습니다. 이러한 기회를 활용하면 기업은 시장에서의 입지를 강화하고 환자의 치료 결과를 개선하는 동시에 지속 가능한 성장을 도모할 수 있습니다.

• 신흥 시장 진출: 신흥 시장, 특히 아시아와 라틴아메리카는 의료 투자 증가와 갑상선 건강에 대한 인식이 높아짐에 따라 큰 성장 잠재력을 가지고 있으며, 기업에게 사업 확장의 길이 될 수 있습니다.
• 병용요법 개발: 갑상선 절제술과 호르몬 요법이나 표적 약물 치료와 같은 다른 치료법을 통합하는 병용요법을 개발할 수 있는 기회가 있으며, 이를 통해 전반적인 효과와 환자 만족도를 높일 수 있습니다.
• 환자 중심 솔루션에 집중: 기업은 교육 프로그램 및 지원 서비스와 같은 환자 중심 솔루션에 투자함으로써 환자의 참여와 인식을 높이고 궁극적으로 갑상선 절제술에 대한 수요를 촉진할 수 있습니다.
• 전략적 파트너십 및 협업: 의료 제공업체, 연구 기관, 기술 기업과의 전략적 파트너십을 통해 혁신을 촉진하고, 새로운 기기의 유통을 확대하며, 시장 침투력을 높이고, 전문지식을 공유할 수 있습니다.
• R&D 투자: R&D에 대한 지속적인 투자는 절제 기술과 기법을 발전시키고, 진화하는 임상적 요구에 부응하며, 치료 결과를 향상시킬 수 있는 새로운 장비를 도입할 수 있도록 하는 데 매우 중요합니다.

갑상선 절제 기기 시장의 전략적 성장 기회는 제조업체와 의료 서비스 제공업체 모두에게 유망한 기회입니다. 확대, 혁신, 협력에 집중함으로써 이해관계자들은 시장에서의 입지를 강화할 수 있을 뿐만 아니라 갑상선 관리에서 환자 치료 개선에 크게 기여할 수 있습니다.

갑상선 절제 기기 시장 성장 촉진요인 및 과제

갑상선 절제 기기 시장은 몇 가지 주요 촉진요인에 힘입어 크게 성장하고 있습니다. 동시에 시장 확대에 영향을 미칠 수 있는 과제도 남아있습니다. 이러한 역학을 이해하는 것은 진화하는 갑상선 치료의 전망을 효과적으로 탐색하고자 하는 이해관계자들에게 매우 중요합니다. 성장의 촉매제와 극복해야 할 장애물을 파악하는 것은 경쟁이 치열한 이 시장에서 전략적 의사결정을 내리는 데 도움이 될 것입니다.

갑상선 절제 기기 시장을 이끄는 요인은 다음과 같습니다.

• 갑상선 질환의 유병률 증가: 갑상선 결절과 암을 포함한 갑상선 질환의 유병률 증가는 효과적인 치료 옵션에 대한 수요를 촉진하고 갑상선 절제술이 의료 서비스 제공업체들 사이에서 점점 더 인기 있는 선택이 되고 있습니다.
• 저침습 기술의 발전: 고주파 절제술, 마이크로파 절제술과 같은 저침습 절제술의 혁신은 더 낮은 침습적 시술을 원하는 환자들을 끌어들여 시장의 성장과 보급에 기여하고 있습니다.
• 인식 및 교육 강화: 갑상선 건강 및 치료 옵션에 대한 환자 및 의료 전문가들의 인식이 높아지면서 갑상선 절제술에 대한 수요가 증가하고 시장 인지도가 높아지고 있습니다.
• 우호적인 규제 환경: 새로운 기기의 승인 절차가 신속히 진행되는 우호적인 규제 환경은 제조업체의 기술 혁신과 첨단 제품 시장 출시를 촉진하고 성장을 더욱 촉진합니다.
• 외래 치료 모델의 확대: 외래 치료 모델로의 전환으로 갑상선 절제술에 대한 접근성이 확대되고 있습니다. 환자들은 회복 시간이 짧고 병원 밖에서 시행할 수 있는 덜 침습적인 옵션을 선호하기 때문입니다.

갑상선 절제 기기 시장의 과제는 다음과 같습니다.

• 높은 장비 비용: 특히 비용에 민감한 의료 시장에서 첨단 갑상선 절제술 장비와 관련된 높은 비용은 도입 장벽이 될 수 있으며, 일부 환자와 의료 서비스 제공업체의 접근을 제한할 수 있습니다.
• 임상 가이드라인의 편차: 지역마다 임상 가이드라인과 치료 프로토콜이 다르기 때문에 의료진 사이에 혼란이 발생하여 갑상선 절제술 기술의 보급을 저해할 수 있습니다.
• 환자들의 낮은 인지도: 인지도 향상에도 불구하고 많은 환자들이 갑상선 절제술을 치료 옵션으로 인식하지 못하고 있으며, 이는 임상에서 이 혁신적인 치료법의 보급을 지연시킬 수 있습니다.

결론적으로, 갑상선 절제 기기 시장은 기술 발전과 환자 인식 증가 등 몇 가지 강력한 촉진요인에 의해 뒷받침되고 있습니다. 그러나 높은 비용과 지침의 불일치 등의 문제가 성장을 저해하는 요인으로 작용할 수 있습니다. 이 진화하는 시장에서 최대한의 영향력을 발휘하고자 하는 이해관계자들은 이러한 과제를 해결하면서 확인된 촉진요인을 활용하는 것이 필수적일 것입니다.

목차

제1장 주요 요약

제2장 세계의 갑상선 절제 기기 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019년-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 갑상선 절제 기기 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 갑상선 절제 기기 시장 : 유형별
  • 고주파 절제
  • 마이크로파 절제
  • 기타
• 세계의 갑상선 절제 기기 시장 : 제품별
  • 열 기반 디바이스
  • 비열 기반 디바이스
• 세계의 갑상선 절제 기기 시장 : 용도별
  • 갑상선 암
  • 갑상선 결절
  • 기타
• 세계의 갑상선 절제 기기 시장 : 최종 용도별
  • 병원
  • 외래수술센터(ASC)
  • 암 전문센터
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019년-2031년)

• 세계의 갑상선 절제 기기 시장 : 지역별
• 북미의 갑상선 절제 기기 시장
• 유럽의 갑상선 절제 기기 시장
• 아시아태평양의 갑상선 절제 기기 시장
• 기타 지역의 갑상선 절제 기기 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 갑상선 절제 기기 시장 성장 기회 : 유형별
  • 세계의 갑상선 절제 기기 시장 성장 기회 : 제품별
  • 세계의 갑상선 절제 기기 시장 성장 기회 : 용도별
  • 세계의 갑상선 절제 기기 시장 성장 기회 : 최종 용도별
  • 세계의 갑상선 절제 기기 시장 성장 기회 : 지역별
• 세계의 갑상선 절제 기기 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 갑상선 절제 기기 시장 생산능력 확대
  • 세계의 갑상선 절제 기기 시장 기업인수합병(M&A), 합병사업
  • 인증 및 라이선싱

제7장 주요 기업 개요

• Boston Scientific Corporation
• BVM Medical System
• Integra Life Sciences
• Johnson & Johnson
• Medtronic
• MedWaves
• Olympus Corporation
• StarMed
• Terumo Europe
• Theraclion

영문목차

The future of the global thyroid ablation device market looks promising, with opportunities in the hospital, ambulatory surgical center, and cancer specialty center markets. The global thyroid ablation device market is expected to grow with a CAGR of 9.7% from 2025 to 2031. The major drivers for this market are the increasing incidence of thyroid cancer and the rising inclination toward minimally invasive procedures.

• Lucintel forecasts that, within the type category, radiofrequency ablation will remain the larger segment over the forecast period due to its advantages, like being quick, safe, and less invasive substitutes for surgery.
• Within the end use category, the hospital will remain the largest segment.
• In terms of region, North America will remain the largest region over the forecast period due to the rising incidence of thyroid cancer and the existence of key players in the region.

Gain valuable insight for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Thyroid Ablation Device Market

The thyroid ablation device market is rapidly evolving, influenced by technological advancements, changing patient preferences, and growing awareness of thyroid-related health issues. As healthcare professionals seek more effective and minimally invasive treatment options, several emerging trends are shaping the future of this market. These trends reflect innovations in device design, treatment methodologies, and patient care strategies, promising improved outcomes for individuals with thyroid disorders.

• Increased Adoption of Radiofrequency Ablation: Radiofrequency ablation (RFA) is gaining traction due to its minimally invasive nature, allowing for targeted destruction of thyroid nodules while preserving surrounding tissue. This leads to quicker recovery times for patients.
• Advancements in Imaging Techniques: Enhanced imaging technologies, such as ultrasound and CT scans, are playing a crucial role in improving the precision of thyroid ablation procedures, enabling better visualization of nodules and real-time monitoring during treatments.
• Development of Novel Devices: Manufacturers are focusing on the development of innovative ablation devices that combine multiple modalities, such as laser and microwave technologies, to improve efficacy, reduce procedure times, and expand treatment indications.
• Growing Patient Awareness: Increased awareness of thyroid disorders and treatment options is driving patient demand for minimally invasive procedures, prompting healthcare providers to adopt ablation techniques as a preferred choice over traditional surgery.
• Regulatory Support for New Technologies: Regulatory bodies are increasingly supportive of novel thyroid ablation devices, expediting approval processes and encouraging research and development. This is likely to spur market growth and innovation in the coming years.

The thyroid ablation device market is witnessing dynamic changes driven by these emerging trends. As technology continues to advance and patient needs evolve, the focus on minimally invasive and effective treatment options will likely dominate the market landscape, ultimately improving patient outcomes and satisfaction.

Recent Developments in the Thyroid Ablation Device Market

The thyroid ablation device market has seen remarkable developments in recent years, driven by technological innovation and an increasing focus on minimally invasive treatment options. These advancements aim to enhance patient outcomes, improve procedural efficiency, and expand the range of treatable conditions. As healthcare providers adopt these innovations, they are reshaping the landscape of thyroid management, providing patients with safer and more effective treatment alternatives.

• Launch of Advanced Ablation Systems: Recent launches of advanced ablation systems featuring improved radiofrequency and microwave technologies are enhancing precision in targeting thyroid nodules, leading to better outcomes and reduced complications.
• Integration of Artificial Intelligence: The integration of artificial intelligence in imaging and procedural planning is revolutionizing thyroid ablation, allowing for more accurate diagnoses and optimized treatment strategies, which significantly improve procedural success rates.
• Growth of Outpatient Procedures: There is a notable shift toward outpatient thyroid ablation procedures, driven by advancements in technology that enable faster recovery and reduced hospital stays, aligning with patient preferences for less invasive treatments.
• Expansion of Clinical Indications: New clinical studies are supporting the use of thyroid ablation for a broader range of indications, including larger nodules and recurrent cases, thereby expanding the patient population eligible for these minimally invasive therapies.
• Regulatory Approvals for Novel Devices: Recent regulatory approvals for innovative thyroid ablation devices are encouraging manufacturers to invest in research and development, fostering a competitive environment that enhances the overall quality and effectiveness of available treatments.

The recent developments in the thyroid ablation device market signal a transformative period for thyroid care. With advancements in technology, procedural approaches, and regulatory support, the future of thyroid management looks promising, offering patients safer and more effective treatment options tailored to their specific needs.

Strategic Growth Opportunities for Thyroid Ablation Device Market

The thyroid ablation device market presents numerous strategic growth opportunities for stakeholders seeking to capitalize on increasing demand for minimally invasive treatments. As awareness of thyroid disorders rises and technological innovations emerge, there are several avenues for expansion. By leveraging these opportunities, companies can enhance their market presence and drive sustainable growth while improving patient care outcomes.

• Expansion into Emerging Markets: Emerging markets, particularly in Asia and Latin America, offer significant growth potential due to rising healthcare investments and increasing awareness of thyroid health, providing an avenue for companies to expand their reach.
• Development of Combination Therapies: There is an opportunity to develop combination therapies that integrate thyroid ablation with other treatment modalities, such as hormonal therapy or targeted drug treatments, which could enhance overall efficacy and patient satisfaction.
• Focus on Patient-Centric Solutions: Companies can invest in patient-centric solutions, such as educational programs and support services, to increase patient engagement and awareness, ultimately driving demand for thyroid ablation procedures.
• Strategic Partnerships and Collaborations: Forming strategic partnerships with healthcare providers, research institutions, and technology firms can facilitate innovation and broaden the distribution of new devices, enhancing market penetration and fostering shared expertise.
• Investment in Research and Development: Continued investment in research and development is crucial for advancing ablation technologies and techniques, enabling the introduction of novel devices that meet evolving clinical needs and improve treatment outcomes.

The strategic growth opportunities within the thyroid ablation device market are promising for manufacturers and healthcare providers alike. By focusing on expansion, innovation, and collaboration, stakeholders can not only enhance their market positions but also significantly contribute to improved patient care in thyroid management.

Thyroid Ablation Device Market Driver and Challenges

The thyroid ablation device market is experiencing significant growth, propelled by several key drivers. At the same time, challenges remain that could impact market expansion. Understanding these dynamics is crucial for stakeholders aiming to navigate the evolving landscape of thyroid care effectively. Identifying both the catalysts for growth and the hurdles to overcome will help inform strategic decisions in this competitive market.

The factors responsible for driving the thyroid ablation device market include:

• Increasing Prevalence of Thyroid Disorders: The rising incidence of thyroid disorders, including nodules and cancer, is driving demand for effective treatment options, making thyroid ablation an increasingly popular choice among healthcare providers.
• Advancements in Minimally Invasive Techniques: Innovations in minimally invasive ablation technologies, such as radiofrequency and microwave ablation, are attracting patients seeking less invasive procedures, contributing to the market's growth and adoption.
• Growing Awareness and Education: Increased awareness of thyroid health and available treatment options among patients and healthcare professionals is fostering greater demand for thyroid ablation procedures, enhancing market visibility.
• Supportive Regulatory Environment: A favorable regulatory environment, with expedited approval processes for new devices, encourages manufacturers to innovate and bring advanced products to market, further driving growth.
• Expanding Outpatient Treatment Models: The shift toward outpatient care models is facilitating greater access to thyroid ablation procedures, as patients prefer shorter recovery times and less invasive options that can be performed outside of hospital settings.

Challenges in the thyroid ablation device market are:

• High Cost of Devices: The high cost associated with advanced thyroid ablation devices can be a barrier to adoption, particularly in cost-sensitive healthcare markets, limiting access for some patients and providers.
• Variability in Clinical Guidelines: Variability in clinical guidelines and treatment protocols across different regions can create confusion among healthcare providers, potentially hindering the widespread adoption of thyroid ablation techniques.
• Limited Awareness Among Patients: Despite growing awareness, many patients remain uninformed about thyroid ablation as a treatment option, which can slow down the uptake of these innovative therapies in clinical practice.

In conclusion, the thyroid ablation device market is buoyed by several strong drivers, including technological advancements and increasing patient awareness. However, challenges such as high costs and variability in guidelines may impede growth. Addressing these challenges while leveraging the identified drivers will be essential for stakeholders aiming to maximize their impact in this evolving market.

List of Thyroid Ablation Device Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, thyroid ablation device companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid ablation device companies profiled in this report include-

• Boston Scientific Corporation
• BVM Medical System
• Integra Life Sciences
• Johnson & Johnson
• Medtronic
• MedWaves
• Olympus Corporation
• StarMed
• Terumo Europe
• Theraclion

Thyroid Ablation Device by Segment

The study includes a forecast for the global thyroid ablation device market by type, product, application, end use, and region.

Thyroid Ablation Device Market by Type [Analysis by Value from 2019 to 2031]:

• Radiofrequency Ablation
• Microwave Ablation
• Others

Thyroid Ablation Device Market by Product [Analysis by Value from 2019 to 2031]:

• Thermal Based Devices
• Non-Thermal Based Devices

Thyroid Ablation Device Market by Application [Analysis by Value from 2019 to 2031]:

• Thyroid Cancer
• Thyroid Nodules
• Others

Thyroid Ablation Device Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Ambulatory Surgical Centers
• Cancer Specialty Centers
• Others

Thyroid Ablation Device Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Thyroid Ablation Device Market

The thyroid ablation device market has seen significant advancements recently, driven by technological innovations, the increasing prevalence of thyroid disorders, and growing awareness of minimally invasive treatment options. These developments are shaping the landscape of healthcare across various countries, including the United States, China, Germany, India, and Japan. Each of these markets is experiencing unique trends that reflect their healthcare needs and economic conditions, fostering a competitive environment for device manufacturers and healthcare providers.

• United States: The U.S. market is witnessing rapid growth due to advancements in ultrasound-guided radiofrequency ablation technology, leading to increased adoption of these procedures among endocrinologists and surgeons.
• China: The thyroid ablation device market in China is expanding quickly, propelled by rising healthcare investments and a growing patient population seeking effective treatments for thyroid nodules and cancer.
• Germany: The German market is characterized by a strong emphasis on research and development, with local manufacturers innovating new technologies to improve efficacy and patient outcomes in thyroid ablation procedures.
• India: The thyroid ablation market in India is evolving as awareness of non-surgical treatment options grows, supported by the increasing incidence of thyroid disorders and the entry of international players into the healthcare sector.
• Japan: Japan is experiencing a surge in thyroid ablation procedures, driven by advancements in imaging technologies and a shift towards minimally invasive treatments, leading to improved patient satisfaction and outcomes.

Features of the Global Thyroid Ablation Device Market

Market Size Estimates: Thyroid ablation device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Thyroid ablation device market size by various segments, such as by type, product, application, end use, and region in terms of value ($B).

Regional Analysis: Thyroid ablation device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, products, applications, end uses, and regions for the thyroid ablation device market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the thyroid ablation device market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the thyroid ablation device market by type (radiofrequency ablation, microwave ablation, and others), product (thermal based devices and non-thermal based devices), application (thyroid cancer, thyroid nodules, and others), end use (hospitals, ambulatory surgical centers, cancer specialty centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Thyroid Ablation Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Thyroid Ablation Device Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Thyroid Ablation Device Market by Type
  • 3.3.1: Radiofrequency Ablation
  • 3.3.2: Microwave Ablation
  • 3.3.3: Others
• 3.4: Global Thyroid Ablation Device Market by Product
  • 3.4.1: Thermal Based Devices
  • 3.4.2: Non-Thermal Based Devices
• 3.5: Global Thyroid Ablation Device Market by Application
  • 3.5.1: Thyroid Cancer
  • 3.5.2: Thyroid Nodules
  • 3.5.3: Others
• 3.6: Global Thyroid Ablation Device Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Ambulatory Surgical Centers
  • 3.6.3: Cancer Specialty Centers
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Thyroid Ablation Device Market by Region
• 4.2: North American Thyroid Ablation Device Market
  • 4.2.1: North American Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.2.2: North American Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others
• 4.3: European Thyroid Ablation Device Market
  • 4.3.1: European Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.3.2: European Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others
• 4.4: APAC Thyroid Ablation Device Market
  • 4.4.1: APAC Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.4.2: APAC Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others
• 4.5: ROW Thyroid Ablation Device Market
  • 4.5.1: ROW Market by Type: Radiofrequency Ablation, Microwave Ablation, and Others
  • 4.5.2: ROW Market by End Use: Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Thyroid Ablation Device Market by Type
  • 6.1.2: Growth Opportunities for the Global Thyroid Ablation Device Market by Product
  • 6.1.3: Growth Opportunities for the Global Thyroid Ablation Device Market by Application
  • 6.1.4: Growth Opportunities for the Global Thyroid Ablation Device Market by End Use
  • 6.1.5: Growth Opportunities for the Global Thyroid Ablation Device Market by Region
• 6.2: Emerging Trends in the Global Thyroid Ablation Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Thyroid Ablation Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Ablation Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Boston Scientific Corporation
• 7.2: BVM Medical System
• 7.3: Integra Life Sciences
• 7.4: Johnson & Johnson
• 7.5: Medtronic
• 7.6: MedWaves
• 7.7: Olympus Corporation
• 7.8: StarMed
• 7.9: Terumo Europe
• 7.10: Theraclion